Riskpilot← Back to searchSign inGet full accessSYNKLINO A/S
A/SActiveCVR 38778676Frederiksborggade 1, 2. thResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20178 employeeswww.synklino.com
Revenue 2024
—
EBITDA margin
—
+6% vs 2023
Equity ratio
59.0%
Financial strength
Net profit 2024
DKK -52,5M
+16% vs 2023
| Revenue | — | — |
| EBITDA | DKK -64,5M | +6% |
| Net profit | DKK -52,5M | +16% |
| Total assets | DKK 34,3M | -69% |
| Equity | DKK 20,2M | -77% |
| Employees | 8 | — |
Legal name
SYNKLINO A/S
CVR number
38778676
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. juli 2017
Share capital
DKK 680.117
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør, af 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med udvikling af lægemidler og hermed forbundet virksomhed.
Address
Frederiksborggade 1, 2. th
Phone
+4520121656
Email
tnk@synklino.com
Website
www.synklino.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 622 | -2.576 | 0 | — | — | — | — |
| Staff expenses | -584 | -2.179 | -4.260 | -4.953 | -17.467 | -19.119 | -15.864 |
| EBITDA | 38 | -4.754 | -9.456 | -11.694 | -59.888 | -68.318 | -64.532 |
| Depreciation & amort. | -0 | -5 | -5 | -14 | -362 | -1.027 | -853 |
| EBIT | 38 | -4.759 | -9.461 | -11.708 | -60.250 | -69.345 | -65.385 |
| Net financials | -3 | -112 | -2.570 | -975 | -2.799 | 1.727 | 7.397 |
| Profit before tax | 35 | -4.871 | -12.030 | -12.683 | -63.049 | -67.618 | -57.989 |
| Tax | 29 | -859 | -1.442 | -1.861 | -5.500 | -5.500 | -5.500 |
| Net profit | 6 | -4.012 | -10.588 | -10.822 | -57.549 | -62.118 | -52.489 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1.523 | 3.019 | 14.482 | 104.700 | 171.712 | 109.154 | 34.255 |
| Equity | 1.056 | -2.956 | -12.500 | 88.843 | 145.746 | 86.835 | 20.210 |
| Long-term debt | 0 | 4.099 | 7.187 | 7.181 | 16.268 | 15.748 | 4.216 |
| Short-term debt | 464 | 1.872 | 19.795 | 8.675 | 9.698 | 6.571 | 9.828 |
| Total debt | 464 | 5.971 | 26.982 | 15.857 | 25.966 | 22.319 | 14.045 |
EBITDA margin
-6453200000.0%
This company
15.8%
Market median
-40843038075% vs market
20182024
Equity ratio
59.0%
This company
38.2%
Market median
+54% vs market
20182024
Return on equity
-259.7%
This company
18.4%
Market median
-1511% vs market
20182024
Net profit margin
-5248900000.0%
This company
8.1%
Market median
-64801234668% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-07-07 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TN Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
STRATEGIC INVESTMENTS A/S | Company | 10.0% | 10.0% | 2026 |
MARIE RUDKJÆR SCHRØDER ApS | Company | 5.0% | 5.0% | 2026 |
Winther Schrøder Holding ApS | Company | 5.0% | 5.0% | 2026 |
Danmarks Eksport- og Investeringsfond | Company | 5.0% | 5.0% | 2023 |
VÆKSTFONDEN | Company | 5.0% | 5.0% | 2021 |
| Individual | 0.0% | 5.0% | 2024 | |
MR BIOINVEST ApS | Company | 15.0% | 15.0% | 2021 |
Maj Invest Minorities I K/S | Company | 25.0% | 25.0% | 2022 |
| Individual | 5.0% | 5.0% | 2022 | |
SYNKLINO A/S | Company | 33.3% | 0.0% | 2024 |
| Individual | 5.0% | 5.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JN-PKN HOLDING ApS
SYNKLINO A/S Board members of SYNKLINO A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Nitschke Kledal | Chief Executive Officer | 0 companies |
| Morten Winther Schrøder | Board of Directors | 0 companies |
| Mads Aage Laustsen | Board of Directors | 0 companies |
| Thomas Feldthus | Board of Directors | 0 companies |
| Mads Lacoppidan | Board of Directors | 0 companies |
| Lene Gerlach | Board of Directors | 0 companies |
| John Sørensen Haurum | Chairman | 0 companies |
| Herwig-Ulf Johannes Richard Meier-Kriesche | Board of Directors | 0 companies |
| Gunnar Magnus Severus Modée Persson | Board of Directors | 0 companies |
| Mette Marie Rosenkilde | Board of Directors | 0 companies |
| Christine Flarup Møller-Jensen | Board of Directors | 0 companies |